Join
Live feed
·
INSIDERFilingvia Quantisnow
Deciphera Pharmaceuticals Inc. logo

Pitman Jama was granted 5,576 shares and sold $25,540 worth of shares (1,662 units at $15.37), increasing direct ownership by 8% to 52,197 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DCPH (Deciphera Pharmaceuticals Inc.) and more on Quantisnow.